BioSpace News Archive

Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention, today announced they will be presenting new scientific data at the American College of Rheumatology’s (ACR/ARHP) Annual Meeting being held November 9-12, 2019 in Atlanta, GA.

DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today the AMA has issued a Proprietary Laboratory Analyses (PLA) Common Procedural Terminology (CPT®) Code for the DermTech Pigmented Lesion Assay.

Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced an update regarding its New Drug Application (NDA) for avapritinib for the treatment of adults with PDGFRA Exon 18 mutant GIST, regardless of prior therapy, and fourth-line GIST.

Annual Award Celebrates 12 EHRs, Health Systems and Pharmacy Industry Leaders for Improving Patient Safety and Workflow Efficiency

Scout Bio, a biotechnology company focused on revolutionizing pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions, today announced the appointment of Anne Traas, DVM, as Chief Development Officer.

CarePredict, the leading AI-powered preventive senior care platform announced today the launch of the third generation of their smart wearable - CarePredict Tempo™ Series 3.

Linaclotide abstract recognized as a Presidential Poster Recipient

Kyocera Corporation (President: Hideo Tanimoto) announced that its smart, portable carbohydrate monitoring system was named the Grand Prix Runner-Up in the Smart X category at the 2019 CEATEC Awards.